san antonio breast cancer symposium 2008: big 1-98: letrozole vs tamoxifen
Published 14 years ago • 1.2K plays • Length 8:11Download video MP4
Download video MP3
Similar videos
-
4:52
san antonio breast cancer symposium 2008: hormone supplements reduce death from breast cancer
-
5:25
san antonio breast cancer symposium 2008: zoledronic acid may have anti-tumour properties
-
6:28
professor mitch dowsett - tamoxifen vs aromatase inhibitors
-
5:48
statin use & cholesterol in estrogen receptor-positive breast cancer treated with endocrine therapy
-
0:27
how to cope with tamoxifen and letrozole
-
10:39
gs2-04: "aromatase inhibitors versus tamoxifen in pre-menopausal women with estrogen receptor..."
-
9:59
gs1-01: "phase 3 study of pembrolizumab chemotherapy vs placebo chemotherapy as neoadjuvant..."
-
16:51
dr. jan liefers gerrit | san antonio breast cancer symposium 2022 | general session
-
0:49
san antonio breast cancer symposium 2022 highlights
-
1:14
how do tamoxifen and femara fight breast cancer? | health
-
23:39
educational sessions: "io vs capecitabine for tnbc"
-
3:27
breast cancer research report from san antonio | dana-farber cancer institute
-
0:53
the side effects of tamoxifen
-
1:01
should you take tamoxifen or letrozole? you need to ask this question...
-
4:00
circulating tumor dna in breast cancer and new data from the san antonio breast cancer symposium
-
1:51:16
dr. bora lim | challenging types of breast cancer | sabcs 2022 | education session
-
13:16
dr. julie doughty: clinical trial results of letrozole vs. tamoxifin
-
15:13
gs3-10: "study of samuraciclib (ct7001), a first-in-class, oral, selective inhibitor of cdk7, in.."